Your browser doesn't support javascript.
loading
Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study.
Qin, Xiao-Qi; An, Gang; Li, Zeng-Jun; Liu, Lan-Ting; Xu, Yan; Yang, Lin-Hua; Ma, Yan-Ping; Deng, Shu-Hui; Sui, Wei-Wei; Qin, Yu; Feng, Xiao-Yan; Zang, Mei-Rong; Yang, Wen-Juan; Zhang, Yan-Ru; Yi, Shu-Hua; Wang, Ting-Yu; Lv, Rui; Zou, De-Hui; Zhao, Yao-Zhong; Qiu, Lu-Gui.
Afiliação
  • Qin XQ; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • An G; Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
  • Li ZJ; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Liu LT; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Xu Y; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Yang LH; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Ma YP; Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
  • Deng SH; Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
  • Sui WW; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Qin Y; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Feng XY; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Zang MR; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Yang WJ; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Zhang YR; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Yi SH; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Wang TY; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Lv R; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Zou DH; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Zhao YZ; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
  • Qiu LG; State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China; and.
Blood Adv ; 3(5): 751-760, 2019 03 12.
Article em En | MEDLINE | ID: mdl-30833275
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas do Mieloma / Resultado do Tratamento / Mieloma Múltiplo Tipo de estudo: Observational_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas do Mieloma / Resultado do Tratamento / Mieloma Múltiplo Tipo de estudo: Observational_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2019 Tipo de documento: Article